Profound Medical Corp. - common stock (PROF)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — Apr 3, 2026Investment Snapshot
- Trading 7% above Graham Number — above intrinsic value estimate
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -65.9%
- Revenue growing at 51% annually
Profound Medical Corp. - common stock (PROF) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $233 million . Key value metrics: P/E ratio 4.2, P/B ratio 3.51, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 2 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Profound Medical Corp. - common stock — Fundamental Analysis Summary
Profound Medical Corp. - common stock (PROF) is currently trading 7% above its Graham Number of $6.03, suggesting the market price exceeds Benjamin Graham's intrinsic value estimate. The stock carries a low trailing P/E ratio of 4.2x.
On financial health, PROF shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -65.9% (sector average: -19.8%), and minimal leverage with a debt-to-equity ratio of 0.11.
StockPik's composite Value Score for PROF is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
PROF reports a high gross margin of 70.9% (sector average: 33.5%) and a negative operating margin of -331.1%.
PROF shows revenue growing at 51% year-over-year, with earnings declining at 53%.